Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Q3 2025 value amounting to $16.6 million.

  • Harmony Biosciences Holdings' Tax Provisions rose 340.86% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.8 million, marking a year-over-year increase of 1005.72%. This contributed to the annual value of $74.3 million for FY2024, which is 2820.64% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Tax Provisions stood at $16.6 million, which was up 340.86% from $9.9 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Tax Provisions high stood at $34.7 million for Q4 2024, and its period low was -$80.0 million during Q3 2022.
  • In the last 5 years, Harmony Biosciences Holdings' Tax Provisions had a median value of $9.8 million in 2023 and averaged $5.6 million.
  • In the last 5 years, Harmony Biosciences Holdings' Tax Provisions tumbled by 876651.88% in 2022 and then surged by 70147.53% in 2023.
  • Harmony Biosciences Holdings' Tax Provisions (Quarter) stood at $5.4 million in 2021, then crashed by 181.34% to -$4.4 million in 2022, then surged by 701.48% to $26.5 million in 2023, then surged by 30.86% to $34.7 million in 2024, then crashed by 52.06% to $16.6 million in 2025.
  • Its last three reported values are $16.6 million in Q3 2025, $9.9 million for Q2 2025, and $11.6 million during Q1 2025.